WuXi AppTec Spring Science Forum
Reserve your seat now by registering HERE
Following the momentum of AACR 2026, we’re continuing the dialogue in the heart of the Cambridge biotech hub. Join us on April 30th for a half-day forum centered on this year’s theme:
“Defining the Next Era of Cancer Therapeutics”
This forum brings together industry leaders and WuXi experts to share thought leadership on the latest advances in oncology R&D in a relaxed atmosphere that fosters meaningful conversation.
During this event, scientific leaders will discuss a range of new modalities in cancer research through insightful talks, a networking cocktail reception, and poster presentations spanning topics such as targeted protein degradation, antibody-drug conjugates, peptide drug discovery, and tumor resistance mechanisms.
This forum will feature two expert panel discussions:
- "Designing the Next Generation of Cancer Drugs" – a chemistry-focused discussion on innovations for emerging cancer therapies
- "From Discovery to IND: A Biology-First Approach to New Modalities" – a biology-focused panel examining how recent advances are shaping the development of novel therapeutic modalities
Attendees will gain exclusive insights from talks highlighting new modalities in cancer research:
📊 1:30 - 3:00 PM | Science Presentations
From Discovery to Candidate Selection
1:30-1:50 PM
DNA-Encoded Libraries and Display Technologies Empower Early Discovery of Peptide Drugs and Peptide-Based Delivery Tools | Dr. Rhys Taylor, Director, WuXi Biology
1:50-2:10 PM
Enabling and Accelerating Targeted Protein Degraders and Molecular Glues Drug Discovery through a Global Open Access Platform | Dr. Tao Guo, Senior Vice President, RCS IPM, WuXi Chemistry
2:10-2:30 PM
Shifting Paradigms in ADC Preclinical Discovery: From Pharmacology to Translational Research | Xiangnan Qiang, Senior Director, WuXi Biology
2:30-2:50 PM
Introduction to DMPK Practices for PROTAC molecules | Dr. Hanlin Tao, Associate Director, DMPK Department, WuXi Testing
☕2:50-3:00 PM | Coffee Break
🎤 3:00-3:45 PM | Panel Discussion
Designing the Next Generation of Cancer Drugs
Moderator: Dr. Tao Guo, Senior Vice President, RCS IPM, WuXi Chemistry
Guest Speakers:
- Dr. Kap-Sun Yeung, Head of Chemistry, Stablix, Inc
- Dr. John Campbell, VP Head of Chemistry, Allorion Therapeutics
- Dr. Janeta Popovici-Muller, Drug Discovery and Biotech Consultant, Third Rock Ventures
🎤 3:45 - 4:30 PM | Panel Discussion
From Discovery to IND: A Biology-First Approach to New Modalities
Moderator: Dr. Jing Li, Executive Director, WuXi Biology
Guest Speakers:
- Dr. Eric Poma, Chief Executive Officer, Calidi Biotherapeutics, Inc
- Eugene Williams, Chief Executive Officer, Autoimmunity BioSolutions
- Dr. Sailaja Buattula, Chief Scientific Officer, Ankyra Therapeutics
🤝 4:30 - 6:00 PM | Poster Gallery & Networking Cocktail Reception
Please kindly note that this event requires pre-registration.
We look forward to welcoming you for an afternoon of meaningful exchanges and fresh perspectives!
